| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/17/2009 | CA2719071A1 (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzenesulfonyl]-1h-pyrrol-3-yl}-acrylamide salts |
| 09/17/2009 | CA2718499A1 Antibody against the csf-1 r |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2717997A1 Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof |
| 09/17/2009 | CA2717854A1 Allogeneic cancer cell-based immunotherapy |
| 09/17/2009 | CA2717812A1 Agent for treating disease |
| 09/17/2009 | CA2717529A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | CA2716919A1 An anti-cd6 monoclonal antibody and use thereof |
| 09/17/2009 | CA2716058A1 Dna vaccines and methods for the prevention of transplantation rejection |
| 09/16/2009 | EP2100882A1 (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts |
| 09/16/2009 | EP2100881A1 Pyrimidyl- or pyridinylaminobenzoic acid derivatives |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100619A1 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2100616A2 Composition of antigen and glycolipid adjuvant sublingual administration |
| 09/16/2009 | EP2100600A1 Extended release oral dosage composition |
| 09/16/2009 | EP2099819A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 09/16/2009 | EP2099800A1 7-substituted purine derivatives for immunosuppression |
| 09/16/2009 | EP2099477A2 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
| 09/16/2009 | EP2099439A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/16/2009 | EP1891961B1 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 09/16/2009 | EP1585515B1 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
| 09/16/2009 | EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses |
| 09/16/2009 | EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101530616A Vaccine adjuvant and vaccine composition |
| 09/16/2009 | CN101530548A Composition with multiple health-care functions and preparation method thereof |
| 09/16/2009 | CN101530472A Preparation method and application of preparation for different extraction parts of biond magnolia flower |
| 09/16/2009 | CN101530471A Preparation drug of rhinitis of biond magnolia flower and preparation method thereof |
| 09/16/2009 | CN101530462A Composition for treating eczema and preparation method thereof |
| 09/16/2009 | CN101530443A Asarum volatile oil prepared by system solvent method and use thereof |
| 09/16/2009 | CN101530442A Asarum volatile oil prepared by vacuum distillation method and use thereof |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530432A Method for producing degreased concentrated solution of tussah male moth |
| 09/16/2009 | CN101530429A New use of clarias lazera |
| 09/16/2009 | CN101530418A A pharmaceutical formulation for treating skin sensibility |
| 09/16/2009 | CN101530394A Polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 and preparation method thereof |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/15/2009 | US7590494 leukotriene A4 (LTA4) hydrolase; identifying enzyme inhibitors, as antiinflammatory agents |
| 09/15/2009 | US7589202 Substituted pyrazoles |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589115 2-[5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories |
| 09/15/2009 | US7589093 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588930 Fusing to the antigen a Listerial truncated ActA protein; listeria vaccine strain |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2330330C Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2149925C Peptidic derivates of .alpha.-msh and their uses |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/11/2009 | WO2009111607A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 09/11/2009 | WO2009111337A1 Compounds and compositions as tlr activity modulators |
| 09/11/2009 | WO2009110944A1 Modified toxins |
| 09/11/2009 | WO2009110519A1 Novel 1-aminocarbonylpiperidine derivative |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110486A1 Inducer for inducing a th1 cell-dominant condition from a th2 cell-dominant condition |
| 09/11/2009 | WO2009109907A1 Novel pyrimidine-pyridine derivatives |
| 09/11/2009 | WO2009109906A1 Pyridine compounds |
| 09/11/2009 | WO2009109904A1 Novel aminomethyl benzene derivatives |
| 09/11/2009 | WO2009109872A1 Pyridin-2-yl derivatives as immunomodulating agents |
| 09/11/2009 | WO2009040069A3 Use of bq-610 alone or in combination with helodermin as a therapeutic agent |
| 09/11/2009 | WO2009033821A3 Use of a peptide as a therapeutic agent |
| 09/11/2009 | WO2009033779A3 Nociceptin for use as a therapeutic agent |
| 09/11/2009 | WO2009033778A3 Mage-3 antigen and others for use as a therapeutic agent |
| 09/11/2009 | WO2009033775A3 Peptide alpmhir alone or in combination with peptide yvpfppf as therapeutic agent |
| 09/11/2009 | WO2009033732A3 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/11/2009 | WO2009033683A3 Galanin message associated peptide alone or in combination with minigastrin as a therapeutic agent |
| 09/11/2009 | CA2716706A1 Compounds and compositions as tlr activity modulators |
| 09/11/2009 | CA2715437A1 Pyridin-2-yl derivatives as immunomodulating agents |
| 09/11/2009 | CA2715317A1 Novel aminomethyl benzene derivatives |
| 09/11/2009 | CA2714665A1 Pyridine compounds |
| 09/11/2009 | CA2714614A1 Novel pyrimidine-pyridine derivatives |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227609 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 09/10/2009 | US20090227602 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/10/2009 | US20090227590 Quaternary ammonium salts as m3 antagonists |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227535 Process for producing natural immunobiotic extract and uses thereof |